CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
China Resources Double-Crane Pharmaceutical Company Limited Company Snapshot
China Resources Double-Crane Pharmaceutical Company Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares China Resources Double-Crane Pharmaceutical Company Limited with three other companies in this sector in CHINA : Kangmei Pharmaceutical Co Ltd (2019 sales of 11.34 billion Chinese Renmimbi [US$1.62 billion] of which 82% was Medicine), Zhejiang Nhu Co Ltd (7.62 billion Chinese Renmimbi [US$1.09 billion] of which 94% was Pharmaceutical Chemicals), and ChangChun High New Technology Industries (7.27 billion Chinese Renmimbi [US$1.04 billion] of which 88% was Pharmaceutical Industry).

Sales Analysis. During the year ended December of 2019, sales at China Resources Double-Crane Pharmaceutical Company Limited were 9.33 billion Chinese Renmimbi (US$1.33 billion). This is an increase of 13.4% versus 2018, when the company's sales were 8.22 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at China Resources Double-Crane Pharmaceutical Company Limited (and since 2014, sales have increased a total of 118%). Sales of Non- Transfusion saw an increase of 19.2% in 2019, from 5.41 billion Chinese Renmimbi to 6.44 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
China Resources Double-Crane Pharmaceutical Company Limited
  Stock Performance Chart for China Resources Double-Crane Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (7/3/2020): 13.43
(Figures in Chinese Renmimbi)
1 Week 3.7%   13 Weeks 6.4%  
4 Weeks 8.0%   52 Weeks 1.8%  
 
China Resources Double-Crane Pharmaceutical Company Limited Key Data:
  Ticker: 600062 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 9,327,923,200
(Year Ending Jan 2020).
Employees: 12,276
  Currency: Chinese Renmimbi Market Cap: 14,010,682,445
  Fiscal Yr Ends: December Shares Outstanding: 1,043,237,710
  Share Type: A Gu Closely Held Shares: 666,732,106
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.